INDEVUS PHARMACEUTICALS INC 4
4 · INDEVUS PHARMACEUTICALS INC · Filed Mar 20, 2009
Insider Transaction Report
Form 4
ENDO PHARMACEUTICALS HOLDINGS INC
10% Owner
Transactions
- Purchase
Common Stock, par value $.001 per share
2009-03-18+197,521→ 70,417,783 total - Purchase
Common Stock, par value $.001 per share
2009-03-19+438,462→ 70,856,245 total
Footnotes (4)
- [F1]On February 23, 2009, Endo and Purchaser announced the commencement of a subsequent offering period, during which these Shares were tendered and accepted for payment. Certain of the Shares tendered during the subsequent offering period were previously delivered through notices of guaranteed delivery during the tender offer. The subsequent offering period expired at 5:00 p.m. on March 18, 2009.
- [F2]Pursuant to the terms of the Agreement & Plan of Merger, dated as of Jan. 5, 2009, by and among Endo Pharmaceuticals Holdings Inc. ("Endo"), BTB Purchaser Inc. ("BTB") and Indevus Pharmaceuticals, Inc. ("Indevus"), Endo (through BTB) commenced a cash tender offer to purchase all of the issued and outstanding shares fo the common stock of Indevus (the "Shares") at a price of $4.50 per share, without interest, plus contractual rights to receive up to an additional $3.00 per Share in contingent cash consideration payments. The initial tender offer period expired at 5:00 p.m.(ET), Fri., Feb. 20, 2009, at which time approximately 55,008,149 Shares had been validly tendered and not withdrawn pursuant to the tender offer and such Shares were accepted for purchase by the Purchaser on Feb. 23, 2009; such number represents the number of Shares in which the Reporting Person has a beneficial interest as of that date.
- [F3]Representing approximately 88.603% of Indevus' outstanding Shares.
- [F4]Representing approximately 89.155% of Indevus' outstanding Shares.